Recombinant Human PEA15, E. coli

Artikelnummer: EKL-PEH1298
Artikelname: Recombinant Human PEA15, E. coli
Artikelnummer: EKL-PEH1298
Hersteller Artikelnummer: PEH1298
Alternativnummer: EKL-PEH1298-10UG,EKL-PEH1298-50UG,EKL-PEH1298-500UG
Hersteller: EnkiLife
Wirt: E. coli
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Alternative Synonym: Astrocytic Phosphoprotein PEA-15, 15 kDa Phosphoprotein Enriched in Astrocytes, Phosphoprotein Enriched in Diabetes, PED, PEA15
Astrocyticphosphoprotein PEA-15 (PEA15) is a death effector domain (DED)-containing protein. PEA15 is mainly expressed in the central nervous system, principally in astrocytes. Increased PEA15 levels affect tumorigenesis and cancer progression. PEA15 is overexpressed in breast cancers and gliomas as well as in type 2 diabetes. PEA15 blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. PEA15 also inhibits RPS6KA3 activities by holding it in the cytoplasm. In addition, PEA15 inhibits both TNFRSF6 and TNFRSF1A mediated CASP8 activity and apoptosis. At present, PEA15 expression is also a significant prognostic marker in ovarian cancer.
Molekulargewicht: 15.3 KDa
NCBI: 15121
Reinheit: Greater than 95% as determined by reducing SDS-PAGE
Anwendungsbeschreibung: Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100µg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.